USA |NASDAQ |USD
Revenues were $1.59M, up by 75.54% from previous year's revenue.
The company reported a net income of $-14.29M.
Cyclo Therapeutics reported a free cash flow of $-15.03M for its fiscal year, compared to $-8.59M a year ago.
The company ended the fiscal year with $170.99K in total debt, a decrease of -12.06% compared to the previous year.